<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Obstetrics and Gynaecology</title>
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@400;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css" integrity="sha512-iecdLmaskl7CVkqkXNQ/ZH/XLlvWZOJyj7Yy7tcenmpD1ypASozpmT/E0iPtmFIB46ZmdtAc9eNBvH0H/ZpiBw==" crossorigin="anonymous" referrerpolicy="no-referrer" />
    <link rel="stylesheet" href="css/textbook.css">
</head>
<body>
    <header>
        <h1>Obsttrics and Gynaecology</h1>
        <h3>&copy; DirimSi Academy | Telegram: @SchrDbb | Phone: +237 6 52 65 94 29</h3>
    </header>
    <button class="toc-button" aria-expanded="false" aria-controls="nav-menu">|||</button>

    <!-- Navigation Menu -->
    <nav id="nav-menu" role="navigation" aria-label="Table of contents">
        <h3>Table of Contents</h3>
        <ul>
            <li><a href="#case1">Case 1: Labor (Latent Phase)</a></li>
            <li><a href="#case2">Case 2: Anemia in Pregnancy (Thalassemia Trait)</a></li>
            <li><a href="#case3">Case 3: Uterine Inversion</a></li>
            <li><a href="#case4">Case 4: Shoulder Dystocia</a></li>
            <li><a href="#case5">Case 5: Fetal Bradycardia (Cord Prolapse)</a></li>
            <li><a href="#case6">Case 6: Postpartum Hemorrhage</a></li>
            <li><a href="#case7">Case 7: Serum Screening in Pregnancy</a></li>
        </ul>
    </nav>

    <!-- Main Content -->
    <main>
	
         <section id="case1">
            <h2>Case 1: Labor (Latent Phase)</h2>
            <p><strong>Summary:</strong> A 26-year-old G1P0 woman at term with an adequate pelvis on clinical pelvimetry, nonimmune rubella status, is in labor. Her cervix has changed from 4- to 5-cm dilation over 2 hours with uterine contractions noted every 2 to 3 minutes.</p>
            <p><strong>Next Step:</strong> Continue to observe the labor.</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Know the normal labor parameters in the latent and active phase for nulliparous and multiparous patients.</li>
                <li>Be familiar with the management of common labor abnormalities and know that normal labor does not require intervention.</li>
                <li>Know that rubella vaccination, as a live-attenuated preparation, should not be administered during pregnancy.</li>
            </ul>
            <p><strong>Considerations:</strong> This patient is at term (37–42 weeks’ gestational age) and in the latent phase of labor (cervical dilation < 6 cm). The appropriate management is observation without intervention, as her labor progress is normal. The nonimmune rubella status indicates the need for postpartum immunization.</p>
            <h3>Approach to Labor Evaluation</h3>
            <p><strong>Definitions:</strong></p>
            <ul>
                <li><strong>Labor:</strong> Cervical change with regular uterine contractions.</li>
                <li><strong>Latent Phase:</strong> Initial part of labor where cervix effaces (thins) rather than dilates (usually < 6 cm).</li>
                <li><strong>Active Phase:</strong> Rapid dilation, usually when cervix is > 6 cm.</li>
                <li><strong>Arrest of Active Phase:</strong> No progress in active phase (≥ 6 cm) with ruptured membranes for 4 hours with adequate contractions, or 6 hours with inadequate contractions.</li>
                <li><strong>Stages of Labor:</strong>
                    <ul>
                        <li>First stage: Onset of labor to complete cervical dilation.</li>
                        <li>Second stage: Complete cervical dilation to delivery of infant.</li>
                        <li>Third stage: Delivery of infant to delivery of placenta.</li>
                    </ul>
                </li>
                <li><strong>Fetal Heart Rate Baseline:</strong> Normally 110–160 bpm. Bradycardia < 110 bpm, tachycardia > 160 bpm.</li>
                <li><strong>Decelerations:</strong> Early (mirror uterine contractions), variable (abrupt dips), late (offset after contractions).</li>
                <li><strong>Accelerations:</strong> Increases above baseline by ≥ 15 bpm for ≥ 15 seconds.</li>
            </ul>
            <h3>Clinical Approach to Labor</h3>
            <p>Normal labor is assessed by cervical change versus time. Normal labor should be expectantly managed. When abnormalities occur, evaluate the three Ps: powers (contractions), passenger (fetus), and pelvis. Oxytocin may be used for inadequate powers. Montevideo units (sum of contraction amplitudes in a 10-minute window) ≥ 200 indicate adequate contractions.</p>
            <p><strong>Table 1–1: Normal Labor Parameters</strong></p>
            <table>
                <tr>
                    <th>Stage</th>
                    <th>Nullipara (Lower Limits)</th>
                    <th>Multipara (Lower Limits)</th>
                </tr>
                <tr>
                    <td>Latent Phase (<6 cm)</td>
                    <td>≤18–20 h</td>
                    <td>≤14 h</td>
                </tr>
                <tr>
                    <td>Active Phase</td>
                    <td>Continued progress</td>
                    <td>Continued progress</td>
                </tr>
                <tr>
                    <td>Second Stage</td>
                    <td>≤3 h (≤4 h with epidural)</td>
                    <td>≤2 h (≤3 h with epidural)</td>
                </tr>
                <tr>
                    <td>Third Stage</td>
                    <td>≤30 min</td>
                    <td>≤30 min</td>
                </tr>
            </table>
            <p><strong>Fetal Heart Rate Monitoring:</strong> Category I (normal) is reassuring; Category II requires monitoring; Category III (e.g., absent variability with recurrent decelerations) indicates severe hypoxia, requiring prompt delivery.</p>
            <p><strong>Figures:</strong></p>
            <ul>
                <li>Figure 1–1: Algorithm for labor management.</li>
                <li>Figure 1–2: Calculating Montevideo units.</li>
                <li>Figure 1–3: Fetal heart rate decelerations (early, late, variable).</li>
            </ul>
            <h3>Safe Prevention of Primary Cesarean Delivery</h3>
            <p>Recommendations from the Consortium of Safe Labor include defining active phase as ≥6 cm dilation, reserving cesarean for arrest after 4 hours of adequate contractions or 6 hours of inadequate contractions with ruptured membranes, and using amnioinfusion for variable decelerations.</p>
            <p><strong>Table 1–2: Consortium Recommendations</strong></p>
            <table>
                <tr>
                    <th>Recommendation</th>
                </tr>
                <tr>
                    <td>1. Prolonged latent phase is not an indication for cesarean.</td>
                </tr>
                <tr>
                    <td>2. Slow but progressive labor in first stage should not lead to cesarean.</td>
                </tr>
                <tr>
                    <td>3. Active phase defined as ≥6 cm dilation.</td>
                </tr>
                <tr>
                    <td>4. Cesarean for active phase arrest after 4 h adequate or 6 h inadequate contractions.</td>
                </tr>
                <tr>
                    <td>5. Second stage arrest: ≥2 h pushing (multiparous), ≥3 h (nulliparous).</td>
                </tr>
                <tr>
                    <td>6. Amnioinfusion for variable decelerations.</td>
                </tr>
                <tr>
                    <td>7. Scalp stimulation to assess fetal acid-base status.</td>
                </tr>
                <tr>
                    <td>8. External cephalic version for malpresentation after 36 weeks.</td>
                </tr>
                <tr>
                    <td>9. Cesarean for macrosomia: ≥5000 g (nondiabetic), ≥4500 g (diabetic).</td>
                </tr>
                <tr>
                    <td>10. Manual rotation for persistent occiput posterior/transverse positions.</td>
                </tr>
            </table>
            <p><strong>Table 1–3: Interventions for Prolonged Decelerations</strong></p>
            <table>
                <tr>
                    <th>Etiology</th>
                    <th>Finding</th>
                    <th>Intervention</th>
                </tr>
                <tr>
                    <td>Tachysystole</td>
                    <td>>5 contractions/10 min over 30 min</td>
                    <td>Decrease/stop oxytocin, beta-mimetic</td>
                </tr>
                <tr>
                    <td>Hypotension</td>
                    <td>Low BP post-epidural/spinal</td>
                    <td>IV fluid bolus, vasopressor (e.g., ephedrine)</td>
                </tr>
                <tr>
                    <td>Rapid cervical dilation</td>
                    <td>Rapid labor progression</td>
                    <td>Positional changes, observation</td>
                </tr>
                <tr>
                    <td>Umbilical cord prolapse</td>
                    <td>Cord through cervix</td>
                    <td>Elevate presenting part, emergency cesarean</td>
                </tr>
                <tr>
                    <td>Placental abruption</td>
                    <td>Uterine tenderness, vaginal bleeding</td>
                    <td>Support BP, consider cesarean</td>
                </tr>
                <tr>
                    <td>Uterine rupture</td>
                    <td>Prior cesarean history</td>
                    <td>Emergency cesarean</td>
                </tr>
            </table>
            <h3>Comprehension Questions</h3>
            <ol>
                <li><strong>1.1</strong> A 31-year-old G2P1 at 39 weeks with contractions every 3–4 min, cervix unchanged at 6 cm for 3 h. Best management? <strong>Answer:</strong> C. Observation.</li>
                <li><strong>1.2</strong> A 26-year-old G2P1 at 41 weeks, pushing 3 h without progress, occiput posterior. Situation? <strong>Answer:</strong> C. Arrest of descent.</li>
                <li><strong>1.3</strong> A 31-year-old G2P1 at 40 weeks, cervix from 5 to 6 cm over 3 h. Labor? <strong>Answer:</strong> E. Normal labor.</li>
                <li><strong>1.4</strong> A 24-year-old G2P1 at 39 weeks with contractions and dark vaginal blood with mucus. Etiology? <strong>Answer:</strong> C. Bloody show.</li>
                <li><strong>1.5</strong> A 24-year-old G2P1001 at 38 weeks requests induction. Best response? <strong>Answer:</strong> C. Induction at 38 weeks increases neonatal complications.</li>
                <li><strong>1.6</strong> A 32-year-old G1P0 at 40 weeks, prolonged latent phase, on oxytocin. Management? <strong>Answer:</strong> B. Continued observation on oxytocin.</li>
                <li><strong>1.7–1.10</strong> Match interventions to clinical situations:
                    <ul>
                        <li>1.7: G. Terbutaline (tachysystole with late decelerations).</li>
                        <li>1.8: F. Scalp stimulation (category II FHR tracing).</li>
                        <li>1.9: A. Amnioinfusion (repetitive variable decelerations).</li>
                        <li>1.10: C. Ephedrine (late decelerations post-epidural hypotension).</li>
                    </ul>
                </li>
            </ol>
            <h3>Clinical Pearls</h3>
            <ul>
                <li>Normal labor is assessed by cervical change vs. time.</li>
                <li>Cesarean for labor abnormalities reserved for active phase arrest with ROM and adequate contractions for ≥4 h, or inadequate for ≥6 h.</li>
                <li>Adequate contractions: >200 Montevideo units or every 2–3 min, firm, lasting 40–60 s.</li>
                <li>Latent labor: <6 cm; active labor: >6 cm.</li>
                <li>Early decelerations: fetal head compression; variable: cord compression; late: hypoxia.</li>
                <li>Fetal scalp stimulation with acceleration suggests pH >7.20.</li>
                <li>Amnioinfusion helpful for variable decelerations.</li>
                <li>Category II FHR patterns vary widely in significance.</li>
            </ul>
            <h3>References</h3>
            <ul>
                <li>ACOG Practice Bulletin 116: Management of intrapartum fetal heart rate tracings, 2010.</li>
                <li>ACOG Obstetric Care Consensus No. 1: Safe prevention of primary cesarean delivery, 2014.</li>
                <li>Williams Obstetrics, 23rd ed., 2010.</li>
                <li>Essentials of Obstetrics and Gynecology, 5th ed., 2009.</li>
            </ul>
        </section>

        <section id="case2">
            <h2>Case 2: Anemia in Pregnancy (Thalassemia Trait)</h2>
            <p><strong>Summary:</strong> A 29-year-old G2P1 at 20 weeks with hemoglobin 9.5 g/dL, MCV 70 fL, elevated Hb A2 (5.5%).</p>
            <p><strong>Diagnosis:</strong> β-thalassemia minor.</p>
            <p><strong>Mechanism:</strong> Decreased β-globin chain production.</p>
            <p><strong>Significance:</strong> Small risk of intrauterine growth restriction; pregnancy usually uncomplicated. Genetic testing for father recommended.</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Know iron deficiency and thalassemia as common microcytic anemia causes.</li>
                <li>Understand folate and B12 deficiency cause macrocytic anemia.</li>
                <li>Know diagnostic approach to anemia in pregnancy.</li>
            </ul>
            <p><strong>Considerations:</strong> Mild anemia (Hb < 10.5 g/dL) with low MCV suggests iron deficiency or thalassemia. Normal iron studies and elevated Hb A2 confirm β-thalassemia minor. Avoid iron overload; offer genetic counseling.</p>
            <h3>Approach to Anemia in Pregnancy</h3>
            <p><strong>Definitions:</strong></p>
            <ul>
                <li><strong>Anemia:</strong> Hb < 10.5 g/dL in pregnancy.</li>
                <li><strong>Iron Deficiency Anemia:</strong> Due to insufficient iron for increased pregnancy demands.</li>
                <li><strong>Thalassemia:</strong> Decreased globin chain production, causing ineffective erythropoiesis and hemolysis.</li>
                <li><strong>Hemolytic Anemia:</strong> Low Hb due to RBC destruction (congenital or acquired).</li>
                <li><strong>G6PD Deficiency:</strong> X-linked condition causing hemolysis with certain drugs.</li>
            </ul>
            <p><strong>Clinical Approach:</strong> Iron deficiency is common due to increased fetal and maternal demands. For mild microcytic anemia, trial iron supplementation. Persistent anemia requires iron studies and hemoglobin electrophoresis. β-thalassemia minor is usually safe but requires genetic counseling. Sickle cell disease increases risks of anemia, crises, and fetal complications.</p>
            <h3>Comprehension Questions</h3>
            <ol>
                <li><strong>2.1</strong> A 30-year-old G1P0 with nausea, Hb 9.0 g/dL, MCV 110 fL. Etiology? <strong>Answer:</strong> B. Folate deficiency.</li>
                <li><strong>2.2</strong> A 29-year-old G2P1 at 28 weeks, Hb 7.0 g/dL, dark urine post-antibiotic. Diagnosis? <strong>Answer:</strong> C. Hemolysis.</li>
                <li><strong>2.3</strong> A 33-year-old G1P0 with sickle cell trait, husband also carrier. Chance of sickle cell disease in baby? <strong>Answer:</strong> D. 1/4.</li>
                <li><strong>2.4</strong> A 36-year-old G2P1, Hb 8.0 g/dL, low WBC, platelets. Diagnosis? <strong>Answer:</strong> D. Acute leukemia.</li>
                <li><strong>2.5</strong> A 31-year-old G3P2, Hb 9.0 g/dL, low platelets, elevated liver enzymes. Diagnosis? <strong>Answer:</strong> B. HELLP syndrome.</li>
                <li><strong>2.6</strong> A 28-year-old G1P0 with sickle cell anemia, acute dyspnea, new lung infiltrate. Treatment? <strong>Answer:</strong> E. Exchange transfusion.</li>
            </ol>
            <h3>Clinical Pearls</h3>
            <ul>
                <li>Iron deficiency is the most common anemia in pregnancy.</li>
                <li>Microcytic anemia: iron deficiency or thalassemia.</li>
                <li>Elevated Hb A2 suggests β-thalassemia; elevated Hb F suggests α-thalassemia.</li>
                <li>Folate deficiency is the most common cause of megaloblastic anemia in pregnancy.</li>
                <li>G6PD deficiency hemolysis triggered by drugs like nitrofurantoin.</li>
                <li>Acute chest syndrome in sickle cell disease treated with exchange transfusion.</li>
            </ul>
            <h3>References</h3>
            <ul>
                <li>ACOG Practice Bulletin 95: Anemia in pregnancy, 2008.</li>
                <li>Williams Obstetrics, 23rd & 24th ed., 2010, 2014.</li>
                <li>Essentials of Obstetrics and Gynecology, 5th ed., 2009.</li>
            </ul>
        </section>

        <section id="case3">
            <h2>Case 3: Uterine Inversion</h2>
            <p><strong>Summary:</strong> A 31-year-old G4P3 with normal vaginal delivery, reddish mass at introitus post-placental delivery.</p>
            <p><strong>Diagnosis:</strong> Uterine inversion.</p>
            <p><strong>Complication:</strong> Postpartum hemorrhage.</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Know signs of spontaneous placental separation.</li>
                <li>Recognize uterine inversion presentation.</li>
                <li>Understand undue cord traction as a common cause.</li>
            </ul>
            <p><strong>Considerations:</strong> Third stage of labor (placental delivery) reached upper limit (28 min). Traction on cord without clear placental separation caused inversion. Immediate management includes volume replacement and uterine repositioning.</p>
            <h3>Approach to Inverted Uterus</h3>
            <p><strong>Definitions:</strong></p>
            <ul>
                <li><strong>Active Management of Third Stage:</strong> Maneuvers to facilitate placental delivery and reduce blood loss.</li>
                <li><strong>Physiologic Management:</strong> Allowing natural placental separation.</li>
                <li><strong>Third Stage:</strong> Infant delivery to placenta delivery (≤30 min).</li>
                <li><strong>Abnormally Retained Placenta:</strong> Third stage >30 min.</li>
                <li><strong>Uterine Inversion:</strong> Fundus moves through cervix into vagina.</li>
                <li><strong>Signs of Placental Separation:</strong> Cord lengthening, gush of blood, globular uterus, uterus rising to anterior abdominal wall.</li>
            </ul>
            <p><strong>Clinical Approach:</strong> Await spontaneous placental separation to prevent inversion. Grand-multiparity and fundal placenta increase risk. Treatment includes immediate assistance, uterine relaxation (e.g., halothane), and replacement, followed by uterotonics.</p>
            <p><strong>Figure 3–1:</strong> Uterine inversion diagram.</p>
            <h3>Comprehension Questions</h3>
            <ol>
                <li><strong>3.1</strong> Placental site predisposing to inversion? <strong>Answer:</strong> A. Fundal.</li>
                <li><strong>3.2</strong> Placenta not delivered after 30 min. Next step? <strong>Answer:</strong> D. Manual extraction.</li>
                <li><strong>3.3</strong> Mechanism of hemorrhage in inversion? <strong>Answer:</strong> B. Inability for myometrial contraction.</li>
                <li><strong>3.4</strong> Nonreducible uterus due to tight cervix. Therapy? <strong>Answer:</strong> C. Halothane anesthesia.</li>
                <li><strong>3.5</strong> Cord clamping for 33-week infant? <strong>Answer:</strong> B. 30–60 seconds.</li>
            </ol>
            <h3>Clinical Pearls</h3>
            <ul>
                <li>Undue cord traction without placental separation causes inversion.</li>
                <li>Hemorrhage due to uterine atony is common in inversion.</li>
                <li>Manual placental extraction after 30 min.</li>
                <li>Active management reduces PPH risk.</li>
            </ul>
            <h3>References</h3>
            <ul>
                <li>ACOG Practice Bulletin 76: Postpartum hemorrhage, 2006.</li>
                <li>Williams Obstetrics, 24th ed., 2014.</li>
                <li>Essentials of Obstetrics and Gynecology, 5th ed., 2009.</li>
            </ul>
        </section>

        <section id="case4">
            <h2>Case 4: Shoulder Dystocia</h2>
            <p><strong>Summary:</strong> A 25-year-old G2P1, obese, at 42 weeks, fetal weight 3700 g. Head delivers, shoulders do not.</p>
            <p><strong>Next Step:</strong> McRoberts maneuver and/or suprapubic pressure.</p>
            <p><strong>Complication:</strong> Maternal: postpartum hemorrhage; neonatal: brachial plexus injury (Erb palsy).</p>
            <p><strong>Maternal Condition:</strong> Gestational diabetes.</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Understand shoulder dystocia risk factors.</li>
                <li>Know initial management maneuvers.</li>
                <li>Recognize neonatal complications.</li>
            </ul>
            <p><strong>Considerations:</strong> Obesity and post-term pregnancy increase macrosomia risk. Prolonged second stage suggests dystocia. “Turtle sign” confirms diagnosis.</p>
            <h3>Approach to Shoulder Dystocia</h3>
            <p><strong>Definitions:</strong></p>
            <ul>
                <li><strong>Shoulder Dystocia:</strong> Inability of shoulders to deliver due to anterior shoulder impaction.</li>
                <li><strong>McRoberts Maneuver:</strong> Hyperflexion of maternal thighs to rotate symphysis pubis.</li>
                <li><strong>Suprapubic Pressure:</strong> Push to move shoulder into oblique plane.</li>
                <li><strong>Erb Palsy:</strong> C5–C6 nerve root injury causing arm weakness.</li>
            </ul>
            <p><strong>Clinical Approach:</strong> Risk factors include prior dystocia, macrosomia, gestational diabetes. First maneuvers: McRoberts and suprapubic pressure. Avoid fundal pressure. Other maneuvers: Wood’s corkscrew, posterior arm delivery, Zavanelli.</p>
            <p><strong>Table 4–1: Common Maneuvers</strong></p>
            <table>
                <tr>
                    <th>Maneuver</th>
                </tr>
                <tr>
                    <td>McRoberts maneuver</td>
                </tr>
                <tr>
                    <td>Suprapubic pressure</td>
                </tr>
                <tr>
                    <td>Wood’s corkscrew</td>
                </tr>
                <tr>
                    <td>Delivery of posterior arm</td>
                </tr>
                <tr>
                    <td>Zavanelli maneuver</td>
                </tr>
            </table>
            <h3>Comprehension Questions</h3>
            <ol>
                <li><strong>4.1</strong> Risk factor for shoulder dystocia? <strong>Answer:</strong> A. Maternal gestational diabetes.</li>
                <li><strong>4.2</strong> Maneuver for shoulder dystocia? <strong>Answer:</strong> B. Suprapubic pressure.</li>
                <li><strong>4.3</strong> Neonatal injury? <strong>Answer:</strong> B. Arm at side, internally rotated.</li>
                <li><strong>4.4–4.6</strong> Match mechanisms:
                    <ul>
                        <li>4.4: B. Posterior arm delivery (reduces shoulder–axilla diameter).</li>
                        <li>4.5: A. McRoberts (anterior rotation of symphysis).</li>
                        <li>4.6: D. Suprapubic pressure (displaces shoulder to oblique).</li>
                    </ul>
                </li>
            </ol>
            <h3>Clinical Pearls</h3>
            <ul>
                <li>Shoulder dystocia is unpredictable.</li>
                <li>Macrosomia, especially with gestational diabetes, is the biggest risk factor.</li>
                <li>Erb palsy is the most common neonatal injury.</li>
                <li>First maneuvers: McRoberts, suprapubic pressure.</li>
                <li>Avoid fundal pressure.</li>
            </ul>
            <h3>References</h3>
            <ul>
                <li>ACOG Practice Bulletin 40: Shoulder dystocia, 2002.</li>
                <li>Williams Obstetrics, 24th ed., 2014.</li>
                <li>Essentials of Obstetrics and Gynecology, 5th ed., 2009.</li>
            </ul>
        </section>

        <section id="case5">
            <h2>Case 5: Fetal Bradycardia (Cord Prolapse)</h2>
            <p><strong>Summary:</strong> A 22-year-old G3P2 at 40 weeks, cervix 5 cm, vertex at –3 station. Post-amniotomy, fetal bradycardia (70–80 bpm) for 3 min.</p>
            <p><strong>Next Step:</strong> Vaginal examination for umbilical cord prolapse.</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Evaluate fetal bradycardia post-rupture of membranes for cord prolapse.</li>
                <li>Know treatment for cord prolapse is emergent cesarean.</li>
                <li>Recognize unengaged presenting part increases prolapse risk.</li>
            </ul>
            <p><strong>Considerations:</strong> Unengaged vertex (–3 station) increases cord prolapse risk. Avoid amniotomy in such cases.</p>
            <h3>Approach to Fetal Bradycardia</h3>
            <p><strong>Definitions:</strong></p>
            <ul>
                <li><strong>Engagement:</strong> Fetal head’s biparietal diameter passes pelvic inlet.</li>
                <li><strong>Fetal Bradycardia:</strong> Baseline < 110 bpm for > 10 min.</li>
                <li><strong>Umbilical Cord Prolapse:</strong> Cord through cervical os ahead of presenting part.</li>
                <li><strong>Artificial Rupture of Membranes:</strong> Perforation of chorioamniotic membranes.</li>
            </ul>
            <p><strong>Clinical Approach:</strong> Confirm bradycardia, improve maternal oxygenation (lateral position, IV fluids, oxygen, stop oxytocin). Vaginal exam to check for cord prolapse. Treatment: elevate presenting part, emergent cesarean.</p>
            <p><strong>Table 5–1: Steps for Fetal Bradycardia</strong></p>
            <table>
                <tr>
                    <th>Step</th>
                </tr>
                <tr>
                    <td>Confirm fetal heart rate</td>
                </tr>
                <tr>
                    <td>Vaginal exam for cord prolapse</td>
                </tr>
                <tr>
                    <td>Positional changes</td>
                </tr>
                <tr>
                    <td>Oxygen</td>
                </tr>
                <tr>
                    <td>IV fluid bolus, pressors if hypotensive</td>
                </tr>
                <tr>
                    <td>Discontinue oxytocin, consider beta-agonist</td>
                </tr>
            </table>
            <h3>Comprehension Questions</h3>
            <ol>
                <li><strong>5.1</strong> Previous cesarean, normal contractions, bradycardia. Accurate statement? <strong>Answer:</strong> B. Fetal heart rate abnormality is most common with uterine rupture.</li>
                <li><strong>5.2</strong> Post-misoprostol, prolonged deceleration. Etiology? <strong>Answer:</strong> D. Uterine hyperstimulation.</li>
                <li><strong>5.3</strong> Late decelerations at 35 weeks. Helpful maneuver? <strong>Answer:</strong> D. Stop oxytocin.</li>
                <li><strong>5.4</strong> 10-min bradycardia, closed cervix. Initial step? <strong>Answer:</strong> E. Assess maternal pulse.</li>
                <li><strong>5.5</strong> Late decelerations post-epidural, hypotension. Next step? <strong>Answer:</strong> B. Ephedrine intravenously.</li>
            </ol>
            <h3>Clinical Pearls</h3>
            <ul>
                <li>First steps for bradycardia: confirm heart rate, check for cord prolapse.</li>
                <li>Cord prolapse treatment: elevate presenting part, emergent cesarean.</li>
                <li>Higher prolapse risk with unengaged vertex, footling breech, or transverse lie.</li>
                <li>Uterine rupture often presents with fetal heart rate abnormalities.</li>
            </ul>
            <h3>References</h3>
            <ul>
                <li>ACOG Practice Bulletin 116: Management of intrapartum fetal heart rate tracings, 2010.</li>
                <li>Williams Obstetrics, 23rd ed., 2010.</li>
                <li>Essentials of Obstetrics and Gynecology, 5th ed., 2009.</li>
            </ul>
        </section>

        <section id="case6">
            <h2>Case 6: Postpartum Hemorrhage</h2>
            <p><strong>Summary:</strong> A 29-year-old G5P4 at 39 weeks with preeclampsia, vaginal delivery, 1000 cc bleeding post-placenta.</p>
            <p><strong>Diagnosis:</strong> Uterine atony.</p>
            <p><strong>Next Step:</strong> IV oxytocin, uterine massage, then prostaglandin F2-alpha or misoprostol if ineffective.</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Know PPH definition.</li>
                <li>Understand uterine atony as most common cause.</li>
                <li>Know treatments and contraindications.</li>
            </ul>
            <p><strong>Considerations:</strong> PPH defined as >500 mL blood loss (vaginal delivery). Uterine atony is likely, exacerbated by preeclampsia and magnesium sulfate. Methylergonovine contraindicated due to hypertension.</p>
            <h3>Approach to Postpartum Hemorrhage</h3>
            <p><strong>Definitions:</strong></p>
            <ul>
                <li><strong>PPH:</strong> >500 mL (vaginal) or >1000 mL (cesarean) blood loss.</li>
                <li><strong>Uterine Atony:</strong> Lack of myometrial contraction, boggy uterus.</li>
                <li><strong>Methylergonovine:</strong> Ergot alkaloid for atony, contraindicated in hypertension.</li>
                <li><strong>Prostaglandin F2-alpha:</strong> Stimulates contraction, contraindicated in asthma.</li>
            </ul>
            <p><strong>Clinical Approach:</strong> First steps: uterine massage, oxytocin. If ineffective, use prostaglandin F2-alpha or misoprostol. If bleeding persists with firm uterus, suspect laceration. Surgical options: uterine artery ligation, B-lynch stitch, or hysterectomy.</p>
            <p><strong>Table 6–1: Risk Factors for Uterine Atony</strong></p>
            <table>
                <tr>
                    <th>Risk Factor</th>
                </tr>
                <tr>
                    <td>Magnesium sulfate</td>
                </tr>
                <tr>
                    <td>Oxytocin during labor</td>
                </tr>
                <tr>
                    <td>Rapid labor/delivery</td>
                </tr>
                <tr>
                    <td>Overdistention (macrosomia, multifetal, hydramnios)</td>
                </tr>
                <tr>
                    <td>Intraamniotic infection</td>
                </tr>
                <tr>
                    <td>Prolonged labor</td>
                </tr>
                <tr>
                    <td>High parity</td>
                </tr>
            </table>
            <p><strong>Table 6–2: Treatment for PPH</strong></p>
            <table>
                <tr>
                    <th>Assessment</th>
                    <th>Intervention</th>
                    <th>Comment</th>
                </tr>
                <tr>
                    <td>Assess hemorrhage</td>
                    <td>Support ABCs</td>
                    <td>Monitor ABCs, BP</td>
                </tr>
                <tr>
                    <td>Palpate fundus</td>
                    <td>Bimanual massage, IV oxytocin if boggy</td>
                    <td>Firm uterus: consider lacerations, coagulopathy</td>
                </tr>
                <tr>
                    <td>Pharmacological</td>
                    <td>Ergot alkaloids, PG F2-alpha, misoprostol</td>
                    <td>Contraindications: ergot (hypertension), PG (asthma)</td>
                </tr>
                <tr>
                    <td>Persistent bleeding</td>
                    <td>Two large-bore IVs, Foley, blood, OR</td>
                    <td>Do not delay surgical intervention</td>
                </tr>
                <tr>
                    <td>Stable</td>
                    <td>Intrauterine balloon, embolization</td>
                    <td>Balloon for tamponade</td>
                </tr>
                <tr>
                    <td>Unstable</td>
                    <td>Laparotomy, compression stitches, ligation</td>
                    <td>Hysterectomy if no childbearing desired</td>
                </tr>
            </table>
            <h3>Comprehension Questions</h3>
            <ol>
                <li><strong>6.1</strong> Cesarean delivery, 1500 mL bleeding. Cause? <strong>Answer:</strong> A. Uterine atony.</li>
                <li><strong>6.2</strong> Vaginal delivery, 700 mL bleeding, firm uterus. Etiology? <strong>Answer:</strong> B. Genital tract laceration.</li>
                <li><strong>6.3</strong> Severe PPH, desires future childbearing. Therapy? <strong>Answer:</strong> B. Hypogastric artery ligation.</li>
                <li><strong>6.4</strong> Bleeding with abruption, venipuncture bleeding. Therapy? <strong>Answer:</strong> E. Correction of coagulopathy.</li>
                <li><strong>6.5</strong> Bleeding 10 days post-delivery. Diagnosis? <strong>Answer:</strong> D. Subinvolution of uterus.</li>
            </ol>
            <h3>Clinical Pearls</h3>
            <ul>
                <li>Uterine atony is the most common PPH cause.</li>
                <li>Firm uterus with bleeding suggests laceration.</li>
                <li>Late PPH often due to subinvolution.</li>
                <li>Ergot alkaloids contraindicated in hypertension; PG F2-alpha in asthma.</li>
                <li>Systematic PPH evaluation: stabilize, address etiology.</li>
            </ul>
            <h3>References</h3>
            <ul>
                <li>ACOG Practice Bulletin 76: Postpartum hemorrhage, 2006.</li>
                <li>Williams Obstetrics, 24th ed., 2014.</li>
                <li>WHO Recommendations for PPH, 2012.</li>
                <li>Essentials of Obstetrics and Gynecology, 5th ed., 2009.</li>
            </ul>
        </section>

        <section id="case7">
            <h2>Case 7: Serum Screening in Pregnancy</h2>
            <p><strong>Summary:</strong> A 20-year-old G1P0 at 16 weeks with msAFP 2.8 MOM.</p>
            <p><strong>Next Step:</strong> Basic obstetric ultrasound for dates and multiple gestations.</p>
            <p><strong>Purpose of msAFP:</strong> Assess risk for open neural tube defects and aneuploidy (e.g., Down syndrome, trisomy 18).</p>
            <h3>Analysis</h3>
            <p><strong>Objectives:</strong></p>
            <ul>
                <li>Know common causes of abnormal serum screening (wrong dates, multiple gestations).</li>
                <li>Elevated msAFP may indicate neural tube defects.</li>
                <li>Low msAFP may indicate Down syndrome.</li>
                <li>Be aware of noninvasive and invasive tests for fetal anomalies/aneuploidy.</li>
                <li>Know teratogens and their fetal effects.</li>
            </ul>
            <p><strong>Considerations:</strong> msAFP at 16–20 weeks is appropriate. Elevated msAFP (2.8 MOM) requires ultrasound to confirm dates and rule out multiples. If still elevated, consider repeating test or amniocentesis at later gestation.</p>
            <h3>Approach to Serum Screening</h3>
            <p><strong>Clinical Approach:</strong> msAFP interpretation depends on accurate gestational age and number of fetuses. Ultrasound is the first step to confirm dates and check for multiples. Elevated msAFP may prompt genetic counseling and amniocentesis.</p>
        </section>

	
	</main>
	
	
	<!----------------FOOTER----------------->
    <footer>
        <p>&copy;DriMS. <br> Contact SchrDbb on <b> (+237) 6 52 65 94 29 </b>, for All your Research Data Analysis and Data Science,
            Software Development, Website Development, Biomedical/Clinical Science Tutorials.</p> <br> <br> <br>
    </footer>
	
	
	
	<!----------------JAVASCRIPT----------------->
     <script src="js/textbook.js"></script>
</body>
</html>-6">
        <ul id="study-categories" class="study-categories space-y-2 mb-4">
            <li class="cursor-pointer py-2 px-4 bg-brown-accent rounded-lg hover:bg-golden-yellow hover:text-brown-dark transition-all" data-topic="skeletal-system">The Skeletal System</li>
            <li class="cursor-pointer py-2 px-4 bg-brown-accent rounded-lg hover:bg-golden-yellow hover:text-brown-dark transition-all" data-topic="cardiovascular-system">The Cardiovascular System</li>
        </ul>
        <div id="notes-display" class="hidden bg-brown-accent p-6 rounded-lg">
            <h2 id="current-note-topic" class="text-xl font-semibold text-golden-yellow mb-4"></h2>
            <div id="note-content" class="text-yellow-text"></div>
            <button id="back-to-categories" class="mt-4 py-2 px-4 bg-golden-yellow text-brown-dark rounded-lg hover:bg-yellow-highlight transition-all">Back to Topics</button>
        </div>
    </main>
    <script src="js/anatomy.js"></script>
</body>
</html>
